AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Hepion Pharmaceuticals, Inc.

$0.07 +$0.01 (+18.33%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0.07
Day Range
$0.06$0.07
Year Range
$0.03$0.11
Market Cap
826.7K
AVG Volume
30.47K
Trailing/Forward PE
-0.29/-
PEG ratio
0.34
Dividend Yield
-
Next Earnings Date
2026-10-14
Primary Exchange
Other OTCUS
Net Income (USD) · TTM
-40M-30M-20M-10M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HEPA Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2-3.19M
26 Q1-2.98M
25 Q4-8.28M
25 Q3-9.17M
25 Q2-13.56M
25 Q1-16.44M
24 Q4-13.19M
24 Q3-22.7M
24 Q2-28.37M
24 Q1-38.52M
Operating Income (USD) · TTM
-40M-30M-20M-10M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HEPA Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2-3.15M
26 Q1-3.68M
25 Q4-4.16M
25 Q3-4.76M
25 Q2-8.69M
25 Q1-15.44M
24 Q4-19.35M
24 Q3-25.36M
24 Q2-31.57M
24 Q1-37.23M
EBITDA (USD) · TTM
-60M-40M-20M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HEPA EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2-2.84M
26 Q1-2.97M
25 Q4-8.24M
25 Q3-3.85M
25 Q2-7.31M
25 Q1-9.9M
24 Q4-9.61M
24 Q3-25.08M
24 Q2-31.67M
24 Q1-41.81M
Cash Flows (USD) · TTM
-40M-30M-20M-10M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HEPA Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2-1.59M
26 Q1-1.58M
25 Q4-3.27M
25 Q3-4.09M
25 Q2-6.16M
25 Q1-15.72M
24 Q4-18.22M
24 Q3-26.07M
24 Q2-34.78M
24 Q1-36.31M
EPS (USD) · TTM
-600-400-200024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HEPA EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q2-0.24
26 Q1-0.26
25 Q4-2.34
25 Q3-13.4
25 Q2-49.57
25 Q1-83.32
24 Q4-109.3
24 Q3-219.34
24 Q2-320.26
24 Q1-470.39
Expenses (USD) · TTM
-10M010M20M30M40MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HEPA Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q23.15M
26 Q13.28M
25 Q43.76M
25 Q34.35M
25 Q28.28M
25 Q115.44M
24 Q419.35M
24 Q325.35M
24 Q231.55M
24 Q137.23M
Shares Outstanding · TTM
-1.5M-1M-500K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HEPA Shares Outstanding · TTM by quarter
PeriodShares Outstanding · TTM
26 Q20
26 Q10
25 Q4-20.78K
25 Q3-49.41K
25 Q2-78.03K
25 Q1-106.66K
24 Q4-791.64K
24 Q3-913.34K
24 Q2-1.2M
24 Q1-115.33K
Employee Count
01020302015201620172018201920202021202220232025
HEPA Employee Count by quarter
PeriodEmployee Count
20252
202322
202225
202120
202013
201912
201814
201721
201615
201514
Free Cash Flow Yield
-200000%-150000%-100000%-50000%0%med -772.78%Jan 25May 25Sep 25Jan 26May 26Sep 26
HEPA Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-139.44%
Sep 26-111.87%
Aug 26-103.62%
Aug 26-131.26%
Aug 26-131.26%
Aug 26-281.88%
Jul 26-295.39%
Jul 26-253.43%
Jul 26-222.27%
Jul 26-225.97%
Jul 26-161.99%
Jun 26-251.08%
Jun 26-225.97%
Jun 26-260.74%
Jun 26-169.48%
May 26-205.03%
May 26-154.07%
May 26-150.65%
May 26-609.98%
May 26-553.2%
Apr 26-848.02%
Apr 26-732.9%
Apr 26-779.22%
Apr 26-632.16%
Mar 26-695.37%
Mar 26-579.48%
Mar 26-560.79%
Mar 26-838.35%
Feb 26-880.27%
Feb 26-880.27%
Feb 26-586.85%
Feb 26-617.74%
Jan 26-1006.03%
Jan 26-607.08%
Jan 26-586.85%
Jan 26-510.3%
Jan 26-586.85%
Dec 25-489.04%
Dec 25-510.3%
Dec 25-510.3%
Dec 25-434.7%
Nov 25-541.71%
Nov 25-414.25%
Nov 25-495.93%
Nov 25-788.55%
Oct 25-812.08%
Oct 25-755.69%
Oct 25-766.33%
Oct 25-688.73%
Oct 25-788.55%
Sep 25-989.27%
Sep 25-971.6%
Sep 25-971.6%
Sep 25-697.56%
Aug 25-812.08%
Aug 25-989.27%
Aug 25-863.64%
Aug 25-8657.14%
Aug 25-12885.04%
Jul 25-9082.9%
Jul 25-13191.83%
Jul 25-9234.28%
Jul 25-8147.9%
Jun 25-7892.55%
Jun 25-6925.71%
Jun 25-7915.1%
Jun 25-9720.3%
May 25-10073.76%
May 25-7195.54%
May 25-154173.58%
May 25-43307.19%
May 25-59589.23%
Apr 25-58988.15%
Apr 25-52651.64%
Apr 25-40187.43%
Apr 25-42158.32%
Mar 25-40410.5%
Mar 25-24249.33%
Mar 25-16866.99%
Mar 25-4542.63%
Feb 25-3078.9%
Feb 25-2271.32%
Feb 25-2119.9%
Feb 25-2298.23%
Jan 25-2160.03%
Jan 25-2035.37%
Jan 25-827.17%
Jan 25-760.67%
Jan 25-609.01%
Dec 24-842.98%
Dec 24-791.72%
Dec 24-657.53%
Dec 24-625.91%
Nov 24-580.75%
Nov 24-583.72%
Nov 24-570.5%
Nov 24-966.44%
Nov 24-922.72%
Oct 24-859.27%
Oct 24-733.22%
Price to Book
00.511.5med 0.29Jun 24Sep 24Jul 25Oct 25Feb 26May 26Sep 26
HEPA Price to Book by quarter
PeriodPrice to Book
Sep 260.89
Sep 261.11
Aug 261.2
Aug 260.95
Aug 260.95
Aug 260.3
Jul 260.29
Jul 260.33
Jul 260.38
Jul 260.38
Jul 260.52
Jun 260.34
Jun 260.38
Jun 260.33
Jun 260.5
May 260.41
May 260.55
May 260.56
May 260.2
May 260.22
Apr 260.14
Apr 260.17
Apr 260.16
Apr 260.19
Mar 260.18
Mar 260.21
Mar 260.22
Mar 260.15
Feb 260.14
Feb 260.14
Feb 260.21
Feb 260.2
Jan 260.12
Jan 260.2
Jan 260.21
Jan 260.24
Jan 260.21
Dec 250.25
Dec 250.24
Dec 250.24
Dec 250.28
Nov 250.23
Nov 250.3
Nov 250.25
Nov 250.21
Oct 250.2
Oct 250.21
Oct 250.21
Oct 250.24
Oct 250.21
Sep 250.16
Sep 250.17
Sep 250.17
Sep 250.23
Aug 250.2
Aug 250.16
Aug 250.19
Aug 250.05
Aug 250.03
Jul 250.04
Jul 250.03
Jul 250.04
Jul 250.05
Jun 250.05
Jun 250.06
Jun 250.05
Jun 250.04
May 250.04
May 250.06
Nov 241.01
Nov 241.06
Oct 241.14
Oct 241.33
Oct 240.95
Oct 241.06
Sep 241.11
Sep 241.14
Sep 241.2
Sep 241.18
Aug 241.36
Aug 241.24
Aug 241.06
Aug 240.38
Aug 240.46
Jul 240.5
Jul 240.64
Jul 240.67
Jul 240.63
Jun 240.64
Jun 240.68
Jun 240.75
Jun 240.74
May 240.85
May 240.76
May 240.31
May 240.3
May 240.35
Apr 240.33
Apr 240.48
Apr 240.52
Hepion Pharmaceuticals, Inc.
HEPA
Stockpicker

Video analysis: HEPA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.